Skip to main content
. 2022 Oct 30;34(5):460–482. doi: 10.21147/j.issn.1000-9604.2022.05.07

Figure 5.

Figure 5

Role of PD-1/PD-L1. PD-1-expressing macrophages exhibit an anti- inflammatory-like surface profile in tumor settings. PD-1 expression is negatively correlated to phagocytic ability of macrophages. PD-L1 antibody treatment promotes cell proliferation of cultured bone marrow-derived macrophages, which is related to the activation of the AKT-mTOR pathway. PD-1, programmed cell death 1; PD-L1, programmed cell death ligand 1.